プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Rita B.に依頼

Belgium

Health Economist, Data Analyst, HTA, Systematic Review and Meta-Analysis, Publications Support | 12+ years of experience

プロフィール概要

A health economist with 12+ years of expertise in academia and industry worldwide. Business strategist. Expert in economic modelling and prediction models, cost-effectiveness analyses, HEOR projects, health technology assessments, the use of real world evidence data, global value dossiers and regulatory affairs, systematic reviews and meta-analyses. Hands-on experience with advanced data science methods. I have experience in creating comprehensive and impactful solutions to support market access for innovations for global clients.

専門分野

• ☆ Data Analysis
• ☆ Predictive Modeling & Analytics
• ☆ Data Collection
• ☆ Statistics
• ☆ Meta-Analysis
• ☆ Medical Statistics
• ☆ Health Data Analysis
• ☆ Trend Analysis
• ☆ Health Policy
• ☆ Economic Policy
• ☆ Drug Development
• ☆ Pharmaceutical Regulatory Affairs
• ☆ Clinical Trials
• ☆ Health Technology Assessment
• ☆ Regulatory Affairs
• ☆ Literature Review
• ☆ Systematic Literature Review
• ☆ Health Economics

サービス

• Writing
• Research
• Consulting
• Data & AI

Writing Technical Writing, Newswriting

Research Market Research, User Research, Meta-Research, Feasibility Study, Fact Checking, Gap Analysis, Systematic Literature Review, Secondary Data Collection

Consulting Regulatory Consulting

Data & AI Predictive Modeling, Statistical Analysis, Big Data Analytics, Data Insights

職務経験

Founder and Lead Scientist

Oraculum Healthcare Consultancy

2月 2021 - 現在

Postdoctoral Fellow

Houston Methodist Research Institute

8月 2018 - 現在

Associate Researcher

University of Liege, Belgium

4月 2015 - 6月 2018

Visiting Postdoctoral Researcher

Houston Methodist Research Institute

1月 2015 - 3月 2015

Postdoctoral Researcher

Hasselt University

10月 2012 - 3月 2015

Visiting Postdoctoral Researcher

Texas Children's Hospital

1月 2014 - 3月 2014

Doctoral Researcher and Graduate Teaching Assistant

Hasselt University

11月 2007 - 3月 2012

Visiting Doctoral Researcher

University of Texas Health Science Center at Houston

10月 2008 - 12月 2008

学歴

PhD (Applied Economics)

Universiteit Hasselt

11月 2007 - 3月 2012

Masters of Science

Hasselt University

9月 2005 - 7月 2007

Bachelor of Science

Hasselt University

9月 2001 - 9月 2004

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

Nima Ahmadi and Farzan Sasangohar and Tariq Nisar and Valerie Danesh and Ethan Larsen and Ineen Sultana and Rita Bosetti(2022). Quantifying Occupational Stress in Intensive Care Unit Nurses: An Applied Naturalistic Study of Correlations Among Stress, Heart Rate, Electrodermal Activity, and Skin Temperature . Human Factors: The Journal of the Human Factors and Ergonomics Society. 64. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 159--172. {SAGE} Publications

Rita Bosetti and Laila Tabatabai and Georges Naufal and Terri Menser and Bita Kash(2021). Comprehensive cost-effectiveness of diabetes management for the underserved in the United States: A systematic review . PLOS ONE. 16. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString e0260139. Public Library of Science ({PLoS})

Basem G. Soliman and Nabil Tariq and Yi Ying Law and Stephanie Yi and Nwabunie Nwana and Rita Bosetti and Bita Kash and Linda W. Moore and A. Osama Gaber and Vadim Sherman(2021). Effectiveness of Bariatric Surgery in Increasing Kidney Transplant Eligibility in Patients with Kidney Failure Requiring Dialysis . Obesity Surgery. Springer Science and Business Media {LLC}

Rita Bosetti and Laila Tabatabai and George Naufal and Rosbel Brito and Bita Kash(2020). New model of integrated care for uncontrolled type 2 diabetes in a retrospective, underserved adult population in the USA: a study protocol for an effectiveness and cost-effectiveness analysis . BMJ Open. 10. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString e038084. {BMJ}

Rita Bosetti and Stephen L Jones(2019). Cost–effectiveness of nanomedicine: estimating the real size of nano-costs . Nanomedicine. 14. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1367--1370. Future Medicine Ltd

Rita Bosetti(2015). Cost–effectiveness of nanomedicine: the path to a future successful and dominant market? . Nanomedicine. 10. (12). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1851--1853. Future Medicine Ltd

Rita Bosetti and Gabriella Ferrandina and Wim Marneffe and Giovanni Scambia and Lode Vereeck(2014). Cost–effectiveness of gemcitabine versus PEGylated liposomal doxorubicin for recurrent or progressive ovarian cancer: comparing chemotherapy with nanotherapy . Nanomedicine. 9. (14). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2175--2186. Future Medicine Ltd

Rita Bosetti and Wim Marneffe and Lode Vereeck(2013). Assessing the need for quality-adjusted cost–effectiveness studies of nanotechnological cancer therapies . Nanomedicine. 8. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 487--497. Future Medicine Ltd

Rita Bosetti and Lode Vereeck(2012). The impact of effective patents on future innovations in nanomedicine . Pharmaceutical Patent Analyst. 1. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 37--43. Future Science Ltd

Rita Bosetti and Lode Vereeck(2011). Future of nanomedicine: obstacles and remedies . Nanomedicine. 6. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 747--755. Future Medicine Ltd